Serial 97086288

Live / Applied — Statement of use — processing complete, to examiner (as of 19 May 2026)

What this means for you

Not registered yet, but its 21 Oct 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97086288
Mark type
Design / logo
Filed
21 Oct 2021
Published for opposition
21 Mar 2023
Attorney of record
Caitlin R. Byczko

Goods and services

  • Class 042 — Scientific and technological services: Pharmaceutical research and development in the field of cancer, carcinomas, sarcomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, neurodegenerative diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders, and rare genetic diseases and disorders; medical, pharmaceutical, and scientific research in the field of cancer, carcinomas, sarcomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, neurodegenerative diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders, and rare genetic diseases and disorders; clinical research and testing services not for medical diagnostic purposes in the field of cancer, carcinomas, sarcomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, neurodegenerative diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders, and rare genetic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals and clinical trials for use in diagnosing, preventing, and treating diseases and disorders, namely, cancer, carcinomas, sarcomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, neurodegenerative diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders, and rare genetic diseases and disorders

Owner

Prosecution history

  • 21 May 2026 — DATA MODIFICATION COMPLETED
  • 21 May 2026 — ASSIGNED TO LIE
  • 19 May 2026 — STATEMENT OF USE PROCESSING COMPLETE
  • 15 May 2026 — USE AMENDMENT FILED
  • 15 May 2026 — TEAS STATEMENT OF USE RECEIVED
  • 04 Dec 2025 — TEAS POST PUBLICATION AMENDMENT RECEIVED
  • 15 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 14 Nov 2025 — SOU EXTENSION 5 GRANTED
  • 12 Nov 2025 — SOU EXTENSION 5 FILED
  • 13 Nov 2025 — SOU TEAS EXTENSION RECEIVED
  • 17 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 16 May 2025 — SOU EXTENSION 4 GRANTED
  • 16 May 2025 — SOU EXTENSION 4 FILED
  • 16 May 2025 — SOU TEAS EXTENSION RECEIVED
  • 14 Jan 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED

View this trademark record on Rightsy